HSGFX vs. BIVIX

Last updated Jun 24, 2026

HSGFX (Hussman Strategic Growth Fund) and BIVIX (Invenomic Fund Institutional Class) are both Long-Short funds. Over the past 5 years, HSGFX returned -3.50%/yr vs 8.80%/yr for BIVIX. At a 0.17 correlation, their price movements are largely independent. HSGFX charges 1.15%/yr vs 3.17%/yr for BIVIX.

Performance

HSGFX vs. BIVIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Hussman Strategic Growth Fund (HSGFX) and Invenomic Fund Institutional Class (BIVIX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, HSGFX achieves a -10.54% return, which is significantly higher than BIVIX's -22.03% return.

HSGFX

• 1D: -0.20%
• 1M: -2.68%
• YTD: -10.54%
• 6M: -10.66%
• 1Y: -18.37%
• 3Y*: -4.74%
• 5Y*: -3.50%
• 10Y*: -3.17%

BIVIX

• 1D: -3.16%
• 1M: -11.08%
• YTD: -22.03%
• 6M: -19.30%
• 1Y: -15.80%
• 3Y*: -7.50%
• 5Y*: 8.80%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

HSGFX vs. BIVIX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
HSGFX Hussman Strategic Growth Fund	-10.54%	6.24%	-6.99%	-11.60%	17.33%	-0.23%	14.52%	-18.87%	8.78%	-5.10%
BIVIX Invenomic Fund Institutional Class	-22.03%	4.63%	-8.81%	16.80%	50.01%	63.81%	11.46%	11.59%	3.68%	8.93%

Correlation

The correlation between HSGFX and BIVIX is 0.56, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.56
Correlation (3Y) Calculated over the trailing 3-year period	0.46
Correlation (5Y) Calculated over the trailing 5-year period	0.33
Correlation (All Time) Calculated using the full available price history since Jun 23, 2017	0.17

Over the past year, HSGFX and BIVIX have become more correlated (0.56) than their long-term average of 0.17, meaning their price movements have been converging.

Return for Risk

HSGFX vs. BIVIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HSGFX

HSGFX Risk / Return Rank: 0
HSGFX Sharpe Ratio Rank: 0
HSGFX Sortino Ratio Rank: 0
HSGFX Omega Ratio Rank: 0
HSGFX Calmar Ratio Rank: 0
HSGFX Martin Ratio Rank: 0

BIVIX

BIVIX Risk / Return Rank: 1
BIVIX Sharpe Ratio Rank: 1
BIVIX Sortino Ratio Rank: 1
BIVIX Omega Ratio Rank: 1
BIVIX Calmar Ratio Rank: 1
BIVIX Martin Ratio Rank: 0

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HSGFX vs. BIVIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Hussman Strategic Growth Fund (HSGFX) and Invenomic Fund Institutional Class (BIVIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	HSGFX	BIVIX	Difference
Sharpe ratio: Return per unit of total volatility	-1.51	-0.61	-0.90
Sortino ratio: Return per unit of downside risk	-2.24	-0.77	-1.47
Omega ratio: Gain probability vs. loss probability	0.77	0.91	-0.15
Calmar ratio: Return relative to maximum drawdown	-1.01	-0.60	-0.41
Martin ratio: Return relative to average drawdown	-2.01	-1.78	-0.23

HSGFX vs. BIVIX - Sharpe Ratio Comparison

The current HSGFX Sharpe Ratio is -1.51, which is lower than the BIVIX Sharpe Ratio of -0.61. The chart below compares the historical Sharpe Ratios of HSGFX and BIVIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

HSGFX vs. BIVIX - Drawdown Comparison

The maximum HSGFX drawdown since its inception was -60.61%, which is greater than BIVIX's maximum drawdown of -26.95%. Use the drawdown chart below to compare losses from any high point for HSGFX and BIVIX.

Drawdown Indicators

	HSGFX	BIVIX	Difference
Max Drawdown Largest peak-to-trough decline	-60.61%	-26.95%	-33.66%
Max Drawdown (1Y) Largest decline over 1 year	-17.98%	-26.95%	+8.97%
Max Drawdown (3Y) Largest decline over 3 years	-24.52%	-26.95%	+2.43%
Max Drawdown (5Y) Largest decline over 5 years	-24.52%	-26.95%	+2.43%
Max Drawdown (10Y) Largest decline over 10 years	-33.41%	—	—
Current Drawdown Current decline from peak	-57.39%	-26.95%	-30.44%
Average Drawdown Average peak-to-trough decline	-26.91%	-5.96%	-20.95%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.33%	9.01%	+0.32%

Volatility

HSGFX vs. BIVIX - Volatility Comparison

The current volatility for Hussman Strategic Growth Fund (HSGFX) is 5.62%, while Invenomic Fund Institutional Class (BIVIX) has a volatility of 12.50%. This indicates that HSGFX experiences smaller price fluctuations and is considered to be less risky than BIVIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HSGFX	BIVIX	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.62%	12.50%	-6.88%
Volatility (6M) Calculated over the trailing 6-month period	10.01%	22.10%	-12.09%
Volatility (1Y) Calculated over the trailing 1-year period	12.28%	26.30%	-14.02%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	11.29%	17.21%	-5.92%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	10.83%	17.40%	-6.57%

HSGFX vs. BIVIX - Expense Ratio Comparison

HSGFX has a 1.15% expense ratio, which is lower than BIVIX's 3.17% expense ratio.

Dividends

HSGFX vs. BIVIX - Dividend Comparison

HSGFX's dividend yield for the trailing twelve months is around 2.60%, less than BIVIX's 2.82% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BIVIX Invenomic Fund Institutional Class	2.82%	2.20%	3.95%	20.15%	27.91%	16.08%	3.15%	3.19%	4.79%	1.21%	0.00%	0.00%
HSGFX Hussman Strategic Growth Fund	2.60%	2.33%	3.00%	3.10%	1.08%	0.42%	0.16%	1.84%	1.19%	0.50%	0.28%	0.56%

Frequently Asked Questions

Can I hold both HSGFX and BIVIX in my portfolio?

HSGFX and BIVIX have a correlation of 0.56, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, HSGFX or BIVIX?

BIVIX has higher volatility (12.50%) compared to HSGFX (5.62%). In terms of maximum drawdown, HSGFX dropped -60.61% vs BIVIX's -26.95%.

Which has better risk-adjusted returns?

BIVIX currently has the higher Sharpe Ratio (-0.61 vs -1.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.